INSMED Inc — Director's Dealing 2024

Jul 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-07-08

Reporting Person: Smith Michael Alexander (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-07-08	Common Stock	F	730	$70.05	Disposed	88727	Direct

Footnotes

F1: Shares withheld by the Company to satisfy tax withholding requirements on vesting of Restricted Stock Units ("RSUs").

F2: Represents the closing price of Common Stock on the vesting date of the RSUs.

F3: Includes 629 shares acquired through the Company's 2018 Employee Stock Purchase Plan.